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Abstract
Performing exercise in a glycogen depleted state increases skeletal muscle lipid utilization and the transcription of genes
regulating mitochondrial b-oxidation. Potential candidates for glycogen-mediated metabolic adaptation are the peroxisome
proliferator activated receptor (PPAR) coactivator-1a (PGC-1a) and the transcription factor/nuclear receptor PPAR-h. It was
therefore the aim of the present study to examine whether acute exercise with or without glycogen manipulation affects
PGC-1a and PPAR-h function in rodent skeletal muscle. Twenty female Wistar rats were randomly assigned to 5 experimental
groups (n = 4): control [CON]; normal glycogen control [NG-C]; normal glycogen exercise [NG-E]; low glycogen control [LG-
C]; and low glycogen exercise [LG-E]). Gastrocnemius (GTN) muscles were collected immediately following exercise and
analyzed for glycogen content, PPAR-h activity via chromatin immunoprecipitation (ChIP) assays, AMPK a1/a2 kinase
activity, and the localization of AMPK and PGC-1a. Exercise reduced muscle glycogen by 47 and 75% relative to CON in the
NG-E and LG-E groups, respectively. Exercise that started with low glycogen (LG-E) finished with higher AMPK-a2 activity
(147%, p,0.05), nuclear AMPK-a2 and PGC-1a, but no difference in AMPK-a1 activity compared to CON. In addition, PPAR-h
binding to the CPT1 promoter was significantly increased only in the LG-E group. Finally, cell reporter studies in contracting
C2C12 myotubes indicated that PPAR-h activity following contraction is sensitive to glucose availability, providing
mechanistic insight into the association between PPAR-h and glycogen content/substrate availability. The present study is
the first to examine PPAR-h activity in skeletal muscle in response to an acute bout of endurance exercise. Our data would
suggest that a factor associated with muscle contraction and/or glycogen depletion activates PPAR-h and initiates AMPK
translocation in skeletal muscle in response to exercise.
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Introduction
Skeletal muscle glycogen content determines an individual’s
capacity to sustain long duration exercise [1]. In the absence of
glycogen, muscle increases its metabolic reliance on free fatty acid
(FFA) oxidation [2]. This metabolic flexibility indicates that an
inverse relationship exists between glycogen content and lipid
utilization in skeletal muscle, which might contribute to the
increased capacity for fat oxidation in skeletal muscle following
endurance training [3].
The glycogen content of skeletal muscle has also been shown to
affect the post exercise transcriptional response [4]. Notably,
reducing glycogen content prior to exercise increases the activation
of key genes involved in mitochondrial biogenesis and lipid
oxidation, suggesting that glycogen content regulates the magni-
tude of skeletal muscle adaptation to endurance exercise [4,5,6].
Accordingly, Hansen et al., [7] hypothesised that training with
depleted glycogen would result in greater muscle adaptation than
the equivalent training with normal or high glycogen levels. Over
a 10-week period, human volunteers performed single leg kicking
exercise every day (normal glycogen) or twice every other day (low
glycogen), with the second session performed with low muscle
glycogen. Following the training period there was a greater
increase in time to exhaustion in the low glycogen group and
increased activity of the b-oxidation and TCA enzymes (3-
hydroxyacyl-CoA dehydrogenase (HAD) and citrate synthase (CS))
[7].
Following a similar training design, we [8] and others [9] have
demonstrated that training in a low glycogen state also leads to
increased FFA oxidation in trained cyclists and increases the
mobilization and utilization of intra-muscular triglycerides
(IMTG) [8]. Given this observation, it has been hypothesized
that alterations in FFA availability, potentially as a consequence of
IMTG breakdown, might function as a signal to initiate molecular
adaptation [3]. Two potential targets for circulating FFA are the
peroxisome proliferator activated receptor family of nuclear
receptors (PPAR) and the transcriptional coactivator PGC-1a
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(peroxisome proliferator activated receptor-c coactivtor-1a) [10].
Two PPAR isoforms, PPAR-a and PPAR-h, are expressed in
skeletal muscle and have been shown to control the expression of a
variety of genes involved in FFA utilization and oxidation [11].
Mice with transgenic expression of an activated form of PPAR-h
display increased expression of genes involved in lipid metabolism
and present resistance to high-fat induced obesity [12] suggesting
that PPAR-h might be the molecular target activated by low
glycogen training.
PGC-1a is a transcriptional co-activator known to target
transcription factors regulating mitochondrial metabolism, fatty
acid oxidation enzymes, and angiogenesis in skeletal muscle [13].
PGC-1a function is highly sensitive to exercise, and has been
suggested to co-ordinate the mitochondrial post-exercise tran-
scriptional response [13], although this process can occur
independently of PGC-1a in both rodent [14] and human
[15,16] exercise models. Consistent with this concept, PGC-1a
muscle-specific transgenic mice display a muscle energetic profile
similar to highly trained athletes [17] and an increased expression
of genes known to be involved in lipid utilization and oxidation
[17].
It was therefore the aim of the present study to examine whether
(1) acute exercise alters PGC-1a/PPAR-h activity or localization
in skeletal muscle, and (2) whether manipulating skeletal muscle
glycogen content alters the exercise-induced PGC-1a/PPAR-h
response.
Materials and Methods
Ethical approval
All procedures were approved by the University of Dundee
research ethics committee and performed under UK Home Office
project licence number 60/3441.
Materials
All reagents were from Sigma Aldrich (UK) unless otherwise
stated. Total AMPK a1/a2 antibodies were described previously
[18]. Antibodies against PGC-1a were obtained from Millipore
(AB3242), Histone H2B from AbCam (ab9408), LDH from Sigma
(L7016). (9212) were from Cell Signaling (Cell Signaling, Danvers,
MA).
Exercise protocol
Twenty, female Wistar rats ,200 g (Charles River Laborato-
ries, Tranent, UK) were used for the study. Running experiments
took place on a 3-lane motorized treadmill (Eco 3/6 Treadmill;
Columbus Instruments, Ohio, USA) with the gradient set at 5%.
The exercise protocol is detailed in Figure 1. Briefly, rats (n = 4)
were separated into five groups consisting of a no exercise control
(CON), normal glycogen control (NG-C), normal glycogen
exercise (NG-EX), low glycogen control (LG-C) and low glycogen
exercise (LG-EX). Each rat received three separate habituation
runs (Day 1, 2 and 3) at 17 m.min-1 lasting 10 mins prior to
commencing the main experimental trial. The main experimental
trial consisted of a 60 min exercise bout at 17 m.min-1 followed by
a second 40 min exercise bout 23 h later (NG-E) or 1 h later (LG-
E). The NG-C and LG-C controls were collected following the
23 h or 1 hr recovery period, before the start of the second
exercise bout to allow for assessment of pre-exercise glycogen
levels in the NG-E and LG-E groups. Immediately upon
completion of exercise, rats were terminated via cervical disloca-
tion following concussion, the gastrocnemius muscles were
dissected and snap frozen in liquid nitrogen.
Tissue collection and homogenization
Tissue was powdered under liquid nitrogen using a mortar and
pestle. 50 mg of gastrocnemius muscle was homogenized in 10-
fold mass excess of ice cold sucrose lysis buffer (50 mM Tris
pH 7.5, 250 mM Sucrose, 1 mM EDTA, 1 mM EGTA, 1%
Triton X 100, 50 mM NaF, 1 mM NaVO4 Na2(PO4)2 and 0.1%
DTT) using a hand held homogenizer (Pro 200, PRO scientific
INC, USA). The homogenate was briefly vortexed and centrifuged
at 4uC/8000xg for 10 mins to remove insoluble material. Protein
concentrations were determined using the DC protein assay (Bio-
Rad, Hercules CA).
Glycogen measurements
Powdered muscle (30 mg) was hydrolyzed in 250 ml of 2 N HCl
by heating at 95uC for 3 h. The solution was neutralized with
250 ml 2 N NaOH, and the resulting free glycosyl units were
assayed spectrophotometrically using a hexokinase-dependent
assay kit from Amresco against glucose standards of known
concentrations [19].
Western blot procedures
Equal aliquots of protein were boiled for 5 minutes in 16
Laemmli sample buffer and separated on 7.5 or 10% gels by SDS-
polyacrylamide gel electrophoresis (PAGE). Following electropho-
resis, proteins were transferred for 1 hour at 100 V to a Protran
nitrocellulose membrane (Whatman, Dassel, Germany), blocked
for 1 hour in 3% milk in TBST (Tris-buffered saline +0.1%
Tween), and then incubated over night at 4uC with appropriate
primary antibody in TBST at 1:1000. The following day,
membranes were washed 36 in TBST before incubation for
1 hour at room temperature with peroxidase-conjugated second-
ary antibodies in TBST at 1:10,000 (Perbio Science, Cramlington,
UK). Antibody binding was detected using an enhanced chemi-
luminescence HRP substrate detection kit (Millipore, Watford,
UK). Imaging and band quantification were carried out using a
ChemiGenius Bioimaging Gel Doc System (Syngene, Cambridge,
UK).
AMPK activity assay
Approximately 50 mg of GTN muscle was suspended in 250 ml
homogenization buffer (50 mm Tris/HCl, 0.25 m mannitol,
50 mm NaF, 5 mm sodium pyrophosphate, 150 mm NaCl,
5 mgml21 soybean trypsin inhibitor, 1 mm DTT, 0.1 mm PMSF,
1% (v/v) Triton X-100) and homogenized using a hand-held
polytron. The samples were left to rotate at 4uC for 30 mins and
then cell debris was pelleted by centrifugation at 17,600 g for
5 min. The supernatants were removed and protein concentration
determined. Sheep anti-AMPK a1 or a2 antibodies (5 mg) were
used to immunoprecipitate AMPK from 200 mg of muscle lysate
for 2 h at 4uC. The immunoprecipitates were washed in
homogenization buffer and then resuspended in assay buffer
(50 mm Hepes, 1 mm DTT, 0.02% (v/v) Brij-35). AMP, [322c
P]-ATP (200 cpm pmol21) and the peptide substrate (AMAR-
AASAAALARRR) were added to the immunoprecipitate at a final
concentration of 200 mm. The assays were carried out for 15 min
at 30uC and terminated by applying 30 ml of the reaction mixture
to P81 papers (Whatman; Maidstone, UK). ATP incorporation
into the peptide substrate was inhibited by placing the filter paper
in 1% orthophosphoric acid. Phosphate incorporation into the
peptide was measured as previously described [20].
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Nuclear protein isolation
Nuclear and cytosolic fractions were isolated as previously
described [21]. Briefly, 50 mg GTN muscle was homogenized
using a commercially available kit (78835: NE-PER; Thermo
Scientific) according to the manufacturers instructions, with the
addition of the complete protease inhibitor mixture (11697498001;
Roche Applied Science). Integrity of nuclear fractions was
confirmed by immunoblotting for the cytosolic enzyme, lactate
dehydrogenase (LDH, L7016; Sigma) and the nuclear protein,
histone H2B (ab9408; AbCam).
Chromatin Immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation experiments were performed
using a commercially available kit according to the manufacturer’s
instructions (Millipore, CA, USA, Cat: 17–295). Briefly, 200 mg of
powdered GTN muscle was rotated end-over-end for 10 mins in
10 ml ice-cold 1% high-grade formaldehyde/PBS. Muscle sam-
ples were homogenized in 250 mL SDS lysis buffer using a hand-
held homogenizer (Pro 200, PRO scientific INC, USA). DNA was
sheared using a hand-held sonicator on ice and the resulting
DNA/protein complexes immunoprecipitated overnight using a
mouse monocolonal PPAR-h antibody (R&D Systems INC, Cat:
PP-K9436-10) or a goat anti-mouse IgG as control (Thermo
Scientific, Cat: 31430). The following day, samples were reversed
crosslinked and DNA extracted. To determine PPAR-h binding to
the CPT1 promoter, primers were designed to flank a 285 bp
region of the CPT1 promoter. The primers used were (FWD 59-
CTGGAGAGGAATGGGACAAC-39) and (REV 59-
ATTGGGGTGGAGAAAACAGA-39) with the RT-qPCR cycle
consisting of an initial 95uC for 5 min, followed by 50 cycles of
95uC for 15 s, 56uC for 15 s and 72uC for 30 s.
Expression plasmids and reporter systems
The 4xACO plasmid was previously described by He and
colleagues [22] and was purchased from Addgene (16533). Briefly
this plasmid contains 4 copies of the prototypic PPAR-responsive
element (PRE) taken from the acyl-CoA oxidase (ACO) gene
promoter, which contains two copies of the core binding sequence
AGGTCA separated by one base pair. The pCMX-PPARb/h
expression vector was generously provided by Professor Dan
Kelly, Sandford-Burnham Medical Research Institute, Lake
Nona, USA and has been described in full [23]. The Renilla
luciferase expression vector (RLuc) was purchased from Promega
(Madison, WI).
C2C12 transient cell transfections
C2C12 myoblasts were obtained from the ATCC. Transient
transfection of PPAR-h, ACO, and RLuc were performed on sub-
confluent C2C12 myoblasts using lipofectamine 2000 reagent
(Invitrogen, Carlsbad, CA) as previously described [24]. 16105
cells were seeded on 6-well plates. The next day, myoblasts were
transfected with 0.25 mg PPARd, 2.00 mg ACO, and 0.50 mg
RLuc, complexed with lipofectamine in 500 ml OptiMEM
transfection media (Invitrogen, Carlsbad, CA) and added to each
well. The next day, cells were washed twice with PBS and placed
in differentiation media (High glucose DMEM, 2% HS, 1% Pen/
strep).
Cell glycogen depletion and contraction
Following transfection, cells were maintained in growth media
for 24 h before shifting to differentiation media (DM; High glucose
DMEM, 2% HS, 1% Pen/strep). After four days, fully differen-
tiated myotubes were washed once with DPBS and transferred to
glucose free DMEM media (LG) or maintained in high glucose
DM. 24 hrs later, media was replenished for 3 or 6 hours and the
cells collected, or the cells were stimulated for 3 h (10 Hz, 0.4 s
contraction, 3.6 s delay) using a pulse width of 0.3 ms and pulse
amplitude of 40 V as previously described [24]. Following
treatment, the media was aspirated; the cells were rinsed in PBS,
and collected in 500 ml of passive lysis buffer (PLB; Madison, WI)
while rocking for 15 min. The lysates were centrifuged at 4uC for 3
minutes at 14,000 g to remove debris. The supernatant (20 ml) was
transferred to a 96-well plate and promoter activity was assayed
using the Dual Luciferase Reporter 1000 Assay System (Promega,
Figure 1. Schematic of the experimental design. Skeletal muscle glycogen content was manipulated using pre-exercise and varying periods of
recovery, prior to a main 45 min exercise trial. Five groups performed 3-days acclimatization to treadmill running. Following which, the CON group
was sacrificed 24 h after the final acclimatization trial, the normal glycogen control (NG-C) ran for 1 hour and then rested 23 h before sacrifice, the
normal glycogen exercise (NG-E) performed a subsequent 45 min run 23 h after the initial 1 hour run, the low glycogen control (LG-C) was collected
1 h after the initial 1 hour run, and the low glycogen exercise group (LG-E) was collected immediately following a 45 min run commenced 1 hour
after the initial 1 hour trial. All experiments took place in the morning to avoid significant alterations in diet and diurnal variation in metabolic
responses.
doi:10.1371/journal.pone.0077200.g001
Molecular Adaptation to Low Glycogen Exercise
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E1980). PPAR-h activity was determined by normalizing firefly
luciferase activity (ACO-luciferase) to renilla luciferase (SV40-
renilla). Absolute renilla was used to determine cell viability and
transfection efficiency and was not different between treatment
groups.
Statistical analysis
One-way analysis of variance ANOVA (BrightStat.com) and
Tukey honestly significant difference posthoc test were used to
determine differences in glycogen content, PPAR-h activity,
AMPKa1/a2 activity, protein localization and phosphorylation
between groups. Values are displayed as mean 6 SEM, with
statistical significance set at 0.05.
Results
Glycogen content
The exercise protocol successfully reduced GTN glycogen
content (Figure 2). As expected, the 23 h recovery period restored
glycogen in the NG-C group without super-compensation,
resulting in the NG groups conducting the second exercise bout
with glycogen concentration similar to the no exercise control
(CON) group (2.160.1 to 2.260.4 nmol.mg.wet wt). Following
the 40 min exercise bout, we observed a 48% reduction in the
NG-E group compared to NG-C (2.260.4 to 1.160.2 nmol.mg.-
wet wt). In contrast, the LG-C group had 40% less glycogen
content than the CON group (2.160.1 to 1.360.3 nmol.mg.wet
wt). At the end of the second exercise bout, the LG-E group had a
75% reduction in total glycogen compared to the CON group
(1.360.3 to 0.560.06 nmol.mg.wet wt).
AMPK a1 activity
AMPK a1 activity was not different between the CON, NG-C
(0.0460.002 to 0.460.001 Units mg/AMPK), or LG-C groups
(CON 0.0460.002 to LG-C 0.360.001 Units mg/AMPK;
Figure 3A). AMPK a1 activity tended to increase following
exercise in the NG-E group (CON 0.0460.002 to NG-E
0.0760.005 Units mg/AMPK) and the LG-E group (CON
0.0460.002 to LG-E 0.0560.006 Units mg/AMPK), but neither
reached statistical significance.
AMPK a2 activity
AMPK a2 activity was not different between the CON, NG-C
(0.0360.004 to 0.0360.003 Units mg/AMPK), or LG-C groups
(CON 0.0360.004 to LG-C 0.0260.001 Units mg/AMPK;
Figure 3B). AMPK a2 activity tended to increase (106%;
p= 0.127) following exercise in the NG-E group (CON
0.0360.002 to NG-E 0.0660.004 Units mg/AMPK). Given the
suppression in AMPK a2 activity in the LG-C group, the change
in AMPK a2 activity following the low glycogen exercise bout was
219% (LG-C 0.0260.001 to LG-C 0.0760.005 Units mg/
AMPK).
PGC-1a, AMPKa1 and AMPKa2 nuclear abundance
PGC-1a nuclear abundance increased in the LG-E group by
52% but was unchanged in any other group (Figure 4). In a similar
manner, AMPKa2 nuclear abundance increased in the LG-E
group by 95%, with no change in AMPKa2 nuclear abundance
was observed in any other group. In contrast to AMPKa2,
AMPKa1 nuclear translocation was not observed with exercise.
Skeletal muscle PPAR-h activity
PPAR-h activity, as assessed by PPAR-h binding to the CPT1
promoter (Figure 5), was observed to increase,400% in the LG-E
group immediately after exercise, with no changes observed in any
of the other groups.
Figure 2. Glycogen levels in the 5 experimental groups.
Glycogen was determined after hydrolysis of 30 mg of muscle tissue.
Glycogen levels are expressed per mg of muscle. * indicates
significantly different than CON and { indicates significantly different
than NG-E and LG-C (p,0.05; n = 4).
doi:10.1371/journal.pone.0077200.g002
Figure 3. AMPK activity following exercise in a normal or low
glycogen environment. The activity of (A) a1-AMPK and (B) a2-AMPK
was determined in each of the 5 groups by IP kinase activity assay. *
indicates significantly different than control (p,0.05; n = 4).
doi:10.1371/journal.pone.0077200.g003
Molecular Adaptation to Low Glycogen Exercise
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Cell PPAR-h activity
In cell culture experiments, glycogen depletion increased
PPAR-h activity 76%, suggesting a direct effect of glycogen
content on PPAR-h activity (Figure 6). In agreement with this
hypothesis, glucose refeeding was characterized by a gradual
suppression of PPAR-h activity, returning to basal activity levels
after 6 hs. When contraction was initiated in a low glucose state,
PPAR-h activity increased 28%. In contrast, performing contrac-
tion in a normal glucose media resulted in a 13% suppression of
PPAR-h activity compared to basal control conditions.
Discussion
In the present study, we assessed the effect of muscle glycogen,
on post exercise signaling mechanisms that may regulate lipid
utilization in skeletal muscle. Importantly, to achieve this, we
manipulated glycogen levels via prior exercise, rather than
nutritional intervention. This is an important point, as this
approach allowed us to investigate the affects of glycogen depletion
and subsequent alteration in endogenous substrate availability,
rather than artificially manipulating substrate content, which may
have directly altered cellular signaling events. The validity of this
approach is seen in the fact that the LG-E group began exercise
with 52% of the glycogen of the CON group and by the end of
exercise displayed a 75% decrease in glycogen content. The
physiological reduction in muscle glycogen content that we report
here is similar to that reported in ex vivo models [25] and following
exercise in vivo [26]. With regard to the exercise protocol, it should
also be noted that we aimed to compare depleted vs replenished
glycogen content, rather than high vs low, as glycogen super-
compensation has previously been shown to alter substrate
Figure 4. Signaling in response to exercise in a normal or low glycogen environment. The localization (A) of a2-AMPK and PGC-1a was
determined following exercise in a normal or glycogen depleted state. Nuclear abundance of (B) a2-AMPK and (C) PGC-1a was determined relative to
histone H2B. * indicates significantly different than control (p,0.05; n = 4).
doi:10.1371/journal.pone.0077200.g004
Figure 5. PPAR-h activity in response to exercise in a normal or
low glycogen environment. Post-exercise skeletal muscle activity of
PPAR-h was determined by chromatin immunoprecipitation (ChIP)
assay followed by qRT-PCR using primers spanning the PPAR-h binding
region in the CPT-1 promoter. * indicates significantly different than
control (p,0.05; n = 4).
doi:10.1371/journal.pone.0077200.g005
Molecular Adaptation to Low Glycogen Exercise
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metabolism and intracellular signaling during and following acute
exercise [26].
The principal finding of the present study was the observation
that PPAR-h transcriptional activity is sensitive to the combined
effect of skeletal muscle contraction and glycogen depletion. We
observed an increase in PPAR-h binding to the CPT-1 promoter
when running exercise was conducted in a glycogen-depleted state
(LG-E). Further, to support our skeletal muscle observations, we
present cell-based evidence that PPAR-h activity is directly
sensitive to glucose availability and glycogen content, and restoring
glucose availability suppresses PPAR-h. Collectively, this data has
important implications for the adaptive response of skeletal muscle
to endurance-type exercise.
Unlike other, more characterized PPAR family members
(PPAR-c and PPAR-a), there is limited information regarding
the role of PPAR-h in skeletal muscle metabolic regulation. PPAR-
h is the most abundant PPAR in skeletal muscle and has been
shown to be enriched in oxidative type I fibers [27]. Given the
association of PPAR-h expression with skeletal muscle oxidative
capacity, it is not surprising that both acute [28,29] and chronic
[30,31] exercise increases PPAR-h mRNA in both rodent and
human skeletal muscle. These observations have therefore led to
the suggestion that PPAR-h activity is under the control of an
exercise-derived factor [3,11], however the precise mechanism for
PPAR-h induction during muscle contraction remains unknown.
One possible mechanism by which exercise may trigger PPAR-h
activation is via the liberation of FFAs, which are PPAR ligands,
from adipose and intramuscular stores. Indeed, Fyffe and
colleagues recently demonstrated that long-chain FFA [C16:0,
C16:1, C18:0 and C18:1] were able to occupy a recombinant
PPAR-h protein ligand binding domain in a ratio of 3:2:1:4, with
ligand binding thought to stabilize the protein in an active state
[32]. Given that endogenous FFA of similar chain length
(palmitate [C16]; palmitoleate [C16:1]; and oleate [C18:1]) have
been shown to have diverse physiological functions in skeletal
muscle [5], determining whether such FFA, or species derived
from these FFA are the endogenous PPAR-h ligand is a key future
question to be addressed.
One interesting caveat with regard to FFA as an in vivo ligand
for PPAR-h during exercise is the recent study by Watt and
colleagues, which demonstrated that treatment with the anti-
lipolytic drug nicotinic acid (causing a reduction in FFA
availability) actually increased PPAR-h mRNA expression follow-
ing acute exercise [29]. Further, treatment of C2C12 myotubes
with long-chain FFA failed to increase PPAR-h expression [33].
Thus, it seems that we are still some way from understanding the
endogenous ligand for PPAR-h in skeletal muscle. Given the
disparity between the activity of PPAR-h target genes and PPAR-h
gene expression, it may also be that the activity of PPAR-h (i.e.
cellular location and binding of PPAR-h to target gene promoters),
rather than increased protein or mRNA abundance is the
important physiological event regarding PPAR-h activity. To
support this hypothesis, the data herein provides the first evidence
that contraction in a glycogen depleted state increases PPAR-h
activity in skeletal muscle.
Given our observation that glycogen depletion was not sufficient
to increase PPAR-h activity in vivo, it would appear that a
contraction-derived signal is required to activate PPAR-h. Little is
known regarding modes of post-translational regulation of PPAR-
h activity. However, phosphorylation has been reported as a mode
of regulation for both PPAR-c and PPAR-a [34]. Exercise in a
glycogen-depleted state is known to result in increased activation
of a host of cell energy sensing kinases [3], all implicated in
mitochondrial adaptation to exercise. Consistent with previous
research, we observed increased AMPK a2 activity and nuclear
abundance following exercise in the LG-E group. These findings
are in agreement with data in both rodents [25] and humans
[26,35], suggesting that contraction mediated activation and
relocalization of AMPK is sensitive to skeletal muscle glycogen
content. Overlap in function between AMPK and PPAR-h has
been reported by Kramer and colleagues who demonstrated that
the PPAR-h agonist GW501516 (GW) increases the activity of
both AMPK and PPAR-h in human primary myotubes [36]. In
contrast, in vivo GW does not activate AMPK and only marginally
increases target gene expression [37]. When GW treatment is
combined with the AMPK activator AICAR, target gene
expression increases 2-3-fold more than with GW alone [37].
This notion is also supported by the recent work by Gan and
coworkers who demonstrated that PPAR-h, but not PPAR-a,
interacted with AMPK to synergistically increase lactate dehydro-
genase (LDH) gene transcription [38]. Collectively this data
suggests that AMPK and PPAR-h may function together to
increase the expression of enzymes important in fatty acid
oxidation. Further, our data suggest that low glycogen drives
AMPK into the nucleus possibly as a result of less direct binding of
AMPK to glycogen. However, the exact mechanism and the
regulatory steps involved remain to be determined.
Figure 6. PPAR-h activity in response to decreased glucose
availability and electrical stimulation. The in vitro activity of PPAR-
h was determined by measuring 4xACO-luciferase expression following
(A) glycogen depletion and repletion, or (B) electrical stimulation in a
glucose depleted or glucose rich environment. * indicates significantly
different than control (p,0.05; n = 6 three independent replicates).
doi:10.1371/journal.pone.0077200.g006
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To confirm the effects of glycogen depletion on PPAR-h
activity, we used an in vitro system to determine the effects of
removing glucose from the medium followed by glucose refeeding
or electrical stimulation (contraction). In accordance with our in
vivo finding, PPAR-h was activated by removal of glucose and
inactivated 6 hours after glucose has been added back to the
medium. Extending these findings, we show that contraction
further increases PPAR-h activity in a low glucose environment,
whereas in a high glucose environment contraction decreased
PPAR-h activity. This finding is strikingly similar to b-HAD levels
in trained humans following 3 weeks of training in either a high or
low glycogen state [8], suggesting that PPAR-h activity may
underlie some of the beneficial effects of low glycogen exercise on
fatty acid metabolism.
Another novel finding of the present study was the observation
that PGC-1a nuclear translocation only occurred in the LG-E
group. Terada and Tabata were the first to observe an increase in
skeletal muscle PGC-1a nuclear abundance following exercise
[39]. Complimentary studies from the same group also showed a
clear association between exercise duration/intensity, the magni-
tude of glycogen depletion, and the amount of PGC-1a nuclear
induction in exercised rat skeletal muscle [40]. Subsequent
research has shown that the nuclear import of PGC-1a appears
to be an initiator of the mitochondrial biogenetic program [41],
and that this process also occurs in humans following acute
endurance [42] and high intensity [43] exercise. However, even
though an increase in skeletal muscle nuclear PGC-1a following
exercise is generally accepted, little is known mechanistically about
the regulation of this process. Future research should focus on
identification of the factors involved in PGC-1a nuclear translo-
cation following exercise.
The present study demonstrates the sensitivity of cellular
signaling to glycogen content. However, important limitations in
the study design should be acknowledged. We were careful to
manipulate glycogen content via exercise, and not nutrition. In
doing so, the LG-E group therefore had successive bouts of
exercise compared to the N-GE group who had a significant rest
period. To minimize the effect of the rest period, we added two
additional control groups (NG-C and LG-C) so that we could
understand cellular signaling prior to the second bout of exercise.
Nevertheless, there remains the possibility that the successive bout
of exercise in the LG-E group may have produced a greater
exercise stimulus, which may have contributed to the exercise
adaptation we observed. However, until a genetic or pharmaco-
logical method is developed to specifically manipulate glycogen
content independent of diet or exercise, these study limitations will
remain.
Conclusion
In conclusion, we report for the first time that exercise and
glycogen regulate the activity of PPAR-h in skeletal muscle.
During exercise in a glycogen-depleted state we observed
increased binding of PPAR-h to the CPT1 promoter, indicative
of increased transcriptional activation of PPAR-h. Further, we also
report that PPAR-h activity in vitro is sensitive to glucose
availability and glycogen content. In addition, we report that the
nuclear translocation of AMPK and PGC-1a is sensitive to
glycogen content. This observation has important implications for
mitochondrial adaption to exercise and provides a potential
mechanism for elevated FFA oxidation in glycogen depleted
skeletal muscle. These observations could potentially underlie the
improved performance seen in recreational [7,8] and elite [44]
athletes who incorporate low glycogen training into their
preparation for long distance events. Further research should
aim at determining the cellular cues by which glycogen depletion
increases PGC-1a/AMPK/PPAR-h activity and the implications
for this with regard to skeletal muscle adaptation following
exercise.
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